Menstrual Disorders PMS & PMDD Premenstrual dysphoric disorder Guide Premenstrual dysphoric disorder Guide Overview Symptoms Causes Diagnosis Treatment What Is Premenstrual Dysphoric Disorder (PMDD)? A more severe form of PMS By Pamela Assid, DNP, RN Published on June 30, 2023 Medically reviewed by Lauren Schlanger, MD Print Table of Contents View All Table of Contents Symptoms Causes Diagnosis Relief Treatment Holistic Approach Next in Premenstrual dysphoric disorder Guide Symptoms of Premenstrual Dysphoric Disorder Hormonal fluctuations causing minor physical discomfort or emotional disturbances are common throughout the menstrual cycle. However, if you experience symptoms leading up to and during your period (menstruation) that are so severe they adversely impact your work, academic, and social life, then you might have premenstrual dysphoric disorder (PMDD). Between 1.3% and 5.3% of menstruating people meet the rigorous diagnostic criteria for PMDD. This article will discuss PMDD symptoms, diagnosis, risk factors, self-care options, and medical treatment. grinvalds / Getty Images Symptoms of Premenstrual Dysphoric Disorder (PMDD) Premenstrual dysphoric disorder begins during ovulation (the luteal phase) and resolves shortly after your period ends. It can occur at any age, from your first period until menopause. PMDD symptoms include the following: Feelings of loneliness, sadness, moodiness, anxiety, irritability, restlessness, or elevated self-criticismDepressed mood and interest in usual activitiesFeelings of hopelessnessFeeling overwhelmedAppetite changes (e.g., overeating or food cravings)Insomnia or hypersomnia (sleeping too much)ForgetfulnessConfusionDifficulty concentratingWater retentionWeight gainPainful or tender breastsSwelling or bloating of breasts or abdomen Talk to a healthcare provider, such as a gynecologist, if you experience such symptoms the week before and during your period. PMS vs. PMDD Premenstrual syndrome (PMS) and PMDD occur during ovulation through the end of menstruation. PMS is a constellation of physical and emotional symptoms, such as bloating, breast tenderness, or moodiness, which tends to be less severe than those of PMDD and does not interfere with your overall quality of life. In contrast, PMDD affects fewer people but causes more physical and mental symptoms, often requiring medication management. PMDD is classified as a mood disorder, whereas PMS is not. PMS vs. PMDD: Understanding the Symptom Differences Why Do Some People Experience PMDD? The exact cause of PMDD is unknown. Some researchers theorize that fluctuations in estrogen and progesterone (sex hormones that play a crucial role in menstruation) cause an adverse reaction in the brain, generating the physical and emotional symptoms associated with PMDD. However, studies have not shown higher levels of estrogen or progesterone in people with PMDD compared to the general population. There is also a lack of scientific evidence that people with PMDD are more sensitive to the cyclical changes of estrogen and progesterone. Science has shown PMDD can be caused or worsened in the following ways: Estrogen and progesterone interactions with mood-regulating hormones (serotonin, y-aminobutyric acid, and dopamine) Estrogen and progesterone fluctuations alter the hormone system (which can cause bloating and swelling) Genetic differences in how genes process certain sex hormones suggest PMDD could be inherited. Brain reactions to allopregnanolone (ALLO, a byproduct of progesterone) may cause increased agitation, anxiety, and negative mood changes in people with PMDD. PMDD can mimic symptoms of other diseases but does not cause or worsen any of the following conditions: Endometriosis Polycystic ovary syndrome (PCOS) Adrenal system disorders Hyperprolactinemia PMDD and Mental Health PMDD does not cause but can exacerbate underlying mental health conditions such as major depressive disorder, panic disorder, persistent depressive disorder, or generalized anxiety disorder. If you have a mental health condition, it is important to see a healthcare provider to determine whether your symptoms result from an underlying health condition or PMDD. No reliable scientific evidence supports PMDD's impacts on bipolar disorders, post-traumatic stress disorder, social phobias, eating disorders, or substance use disorders. Diagnostic Criteria for PMDD There are no laboratory or imaging tests for diagnosing PMDD. However, depending on your symptoms, a healthcare provider may order lab testing to rule out any underlying medical issues. A provider may instruct you to track your daily symptoms over two menstrual cycles. The diagnosis is made based on the symptoms persisting over three prior menstrual cycles. The timing of the symptoms is as important as the symptoms themselves. A provider will want to know whether they are present during the week before your period, improve within the first few days, and decline or resolve in the week after your period. The criteria for a PMDD diagnosis include at least five baseline symptoms or additional symptoms that are hurting your social, academic, or work performance or interpersonal relationships. Baseline Symptoms Mood swings, heightened sensitivity to rejection, or sadness or tearfulness Increased irritability or anger or interpersonal conflicts Increased depressed mood, feelings of hopelessness or self-criticism Increased feelings of being hyped up or on edge, anxiety, or tension Additional Symptoms Less interest in usual activities such as school, work, hobbies, or friends Difficulty concentrating Decreased energy and increased fatigue or lethargy Significant changes in appetite (e.g., overeating or cravings) Insomnia or hypersomnia Feeling overwhelmed or out of control Physical symptoms, including joint or muscle pain, feeling bloated, weight gain, and breast tenderness or swelling PMDD Relief: Self-Care at Home PMDD can cause physical and emotional symptoms. You can manage some of the symptoms through self-care techniques, including the following: Cognitive behavioral therapy Aerobic exercise Supplementation (calcium) Other supportive measures are not as well studied but are lower-risk and worth considering, including the following: Dietary modifications such as low salt, low caffeine, and no alcoholStress managementJournaling your symptomsDiscussing symptoms with family members and friends PMDD Medical Treatment The severity of physical and emotional symptoms, which often requires medication management, differentiates PMDD from PMS. If you have PMDD, a healthcare provider may prescribe medication to relieve the physical and emotional symptoms associated with the disorder. Medications for PMDD aim to manage symptoms by enhancing the effectiveness of neurotransmitters (chemical messengers in the brain) tied to mood regulation. Others aim to manage hormonal activity by suppressing ovulation. Treatments may include the following: Selective serotonin reuptake inhibitors (SSRIs): SSRIs are the primary approved medication for PMDD. Some of the most effective SSRIs for PMDD are Zoloft (sertraline), Paxil (paroxetine), Prozac (fluoxetine), Celexa (citalopram), and Lexapro (escitalopram). Serotonin-norepinephrine reuptake inhibitors (SNRIs): Although less common, healthcare providers consider off-label use of Effexor (venlafaxine) for people with significant psychological symptoms. Seroquel (quetiapine): Some people benefit from the medication quetiapine in combination with SSRIs or SNRIs to improve their effectiveness with symptoms such as mood changes, anxiety, and irritability. Oral contraceptives: Several studies show that oral contraceptives can relieve physical and emotional symptoms associated with PMDD. Gonadotropin-releasing hormone agonists (GnRH agonists): GnRH agonists suppress estrogen production, which stops menstruation (period bleeding) or induces menopause. Because long-term use of GnRH agonists increases cardiovascular and osteoporosis risks, they are not indicated for long-term use. How does menopause affect PMDD? PMDD is created by estrogen and progesterone hormone fluctuation during ovulation and menses (your period). During menopause, estrogen and progesterone no longer fluctuate because there is no need for the ovaries to release an egg for fertilization. People in menopause do not suffer the effects of PMDD. Thinking About PMDD Holistically Holistic approaches to managing PMDD physical and emotional symptoms are available: Cognitive behavioral therapy (CBT): Various scientific studies have shown that CBT improves quality of life and depression scores for people with PMDD. Although these studies did not define frequency or duration, they did highlight that mindfulness-based exercises and acceptance-based CBT might be helpful in the management of PMDD symptoms.Herbal preparations and acupuncture: Some people may use herbs or acupuncture to relieve their symptoms. However, more research is necessary to determine the efficacy of these approaches. Summary PMDD affects between 1.3% and 5.3% of people with periods and causes significant physical and emotional disturbances, impacting their quality of life. There are different treatment options for managing PMDD, but the most common therapy is medication management with SSRIs. If you struggle with PMDD, work closely with a healthcare provider or specialist, such as a gynecologist, to determine the best treatment for managing your symptoms. 6 Sources Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy. Hofmeister S, Bodden S. Premenstrual syndrome and premenstrual dysphoric disorder. American Family Physicians. 2016;94(3):236-240. Royal College of Obstetricians and Gynaecologists (RCOG). Premenstrual dysphoric disorder. International Association for Premenstrual Disorders. Evidence-based management of premenstrual disorders (PMDs). Hantsoo L, Epperson CN. Allopregnanolone in premenstrual dysphoric disorder (PMDD): evidence for dysregulated sensitivity to GABA-A receptor modulating neuroactive steroids across the menstrual cycle. Neurobiol Stress. 2020;12:100213. 2020. doi:10.1016/j.ynstr.2020.100213 Sepede G, Sarchione F, Matarazzo I, et al. Premenstrual dysphoric disorder without comorbid psychiatric conditions: a systematic review of therapeutic options. Clin Neuropharmacol. 2016;39(5):241-261. doi:10.1097/WNF.0000000000000173 U.S. Food and Drug Administration. Information about drospirenone. By Pamela Assid, DNP, RN Dr. Assid is a Doctor of Nursing Practice and Certified Professional in Healthcare Quality based in Colorado. See Our Editorial Process Meet Our Medical Expert Board Share Feedback Was this page helpful? Thanks for your feedback! What is your feedback? Other Helpful Report an Error Submit